Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides

Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides

Published 3 months, 3 weeks ago
Description
In today's Pharmaceutical Executive Daily, an FDA advisory panel narrowly votes to recommend easing restrictions on four unapproved peptides, a supply chain expert discusses how China's export controls are exposing vulnerabilities in the U.S. pharmaceutical supply chain, and a pharmacy benefits executive lays out a business case for more targeted employer-based GLP-1 coverage.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us